Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009 - PubMed (original) (raw)
. 2014 May 7;311(17):1778-86.
doi: 10.1001/jama.2014.3201.
Elizabeth J Mayer-Davis 2, Sharon Saydah 3, Giuseppina Imperatore 3, Barbara Linder 4, Jasmin Divers 5, Ronny Bell 6, Angela Badaru 7, Jennifer W Talton 5, Tessa Crume 1, Angela D Liese 8, Anwar T Merchant 8, Jean M Lawrence 9, Kristi Reynolds 9, Lawrence Dolan 10, Lenna L Liu 11, Richard F Hamman 1; SEARCH for Diabetes in Youth Study
Collaborators, Affiliations
- PMID: 24794371
- PMCID: PMC4368900
- DOI: 10.1001/jama.2014.3201
Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009
Dana Dabelea et al. JAMA. 2014.
Abstract
Importance: Despite concern about an "epidemic," there are limited data on trends in prevalence of either type 1 or type 2 diabetes across US race and ethnic groups.
Objective: To estimate changes in the prevalence of type 1 and type 2 diabetes in US youth, by sex, age, and race/ethnicity between 2001 and 2009.
Design, setting, and participants: Case patients were ascertained in 4 geographic areas and 1 managed health care plan. The study population was determined by the 2001 and 2009 bridged-race intercensal population estimates for geographic sites and membership counts for the health plan.
Main outcomes and measures: Prevalence (per 1000) of physician-diagnosed type 1 diabetes in youth aged 0 through 19 years and type 2 diabetes in youth aged 10 through 19 years.
Results: In 2001, 4958 of 3.3 million youth were diagnosed with type 1 diabetes for a prevalence of 1.48 per 1000 (95% CI, 1.44-1.52). In 2009, 6666 of 3.4 million youth were diagnosed with type 1 diabetes for a prevalence of 1.93 per 1000 (95% CI, 1.88-1.97). In 2009, the highest prevalence of type 1 diabetes was 2.55 per 1000 among white youth (95% CI, 2.48-2.62) and the lowest was 0.35 per 1000 in American Indian youth (95% CI, 0.26-0.47) and type 1 diabetes increased between 2001 and 2009 in all sex, age, and race/ethnic subgroups except for those with the lowest prevalence (age 0-4 years and American Indians). Adjusted for completeness of ascertainment, there was a 21.1% (95% CI, 15.6%-27.0%) increase in type 1 diabetes over 8 years. In 2001, 588 of 1.7 million youth were diagnosed with type 2 diabetes for a prevalence of 0.34 per 1000 (95% CI, 0.31-0.37). In 2009, 819 of 1.8 million were diagnosed with type 2 diabetes for a prevalence of 0.46 per 1000 (95% CI, 0.43-0.49). In 2009, the prevalence of type 2 diabetes was 1.20 per 1000 among American Indian youth (95% CI, 0.96-1.51); 1.06 per 1000 among black youth (95% CI, 0.93-1.22); 0.79 per 1000 among Hispanic youth (95% CI, 0.70-0.88); and 0.17 per 1000 among white youth (95% CI, 0.15-0.20). Significant increases occurred between 2001 and 2009 in both sexes, all age-groups, and in white, Hispanic, and black youth, with no significant changes for Asian Pacific Islanders and American Indians. Adjusted for completeness of ascertainment, there was a 30.5% (95% CI, 17.3%-45.1%) overall increase in type 2 diabetes.
Conclusions and relevance: Between 2001 and 2009 in 5 areas of the United States, the prevalence of both type 1 and type 2 diabetes among children and adolescents increased. Further studies are required to determine the causes of these increases.
Conflict of interest statement
Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Liese reported that she has received grant support from the National Institutes of Health, Centers for Disease Control and Prevention (CDC), American Diabetes Association, American Heart Association, US Department of Agriculture, Juvenile Diabetes Research Foundation, and the US Army Medical Research Acquisition Activity; personal fees from the National Institutes of Health and the US Department of Agriculture; and Dr Reynolds reported receiving grant support from Merck. No other financial disclosures were reported.
Comment in
- Diabetes prevalence among youth.
Demmer RT, Zuk AM, Rosenbaum M. Demmer RT, et al. JAMA. 2014 Sep 17;312(11):1153. doi: 10.1001/jama.2014.9617. JAMA. 2014. PMID: 25226483 No abstract available. - Diabetes prevalence among youth--reply.
Dabelea D, Mayer-Davis EJ. Dabelea D, et al. JAMA. 2014 Sep 17;312(11):1153-4. doi: 10.1001/jama.2014.9620. JAMA. 2014. PMID: 25226484 No abstract available.
Similar articles
- The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study.
SEARCH for Diabetes in Youth Study Group; Liese AD, D'Agostino RB Jr, Hamman RF, Kilgo PD, Lawrence JM, Liu LL, Loots B, Linder B, Marcovina S, Rodriguez B, Standiford D, Williams DE. SEARCH for Diabetes in Youth Study Group, et al. Pediatrics. 2006 Oct;118(4):1510-8. doi: 10.1542/peds.2006-0690. Pediatrics. 2006. PMID: 17015542 - Trends in Prevalence of Type 1 and Type 2 Diabetes in Children and Adolescents in the US, 2001-2017.
Lawrence JM, Divers J, Isom S, Saydah S, Imperatore G, Pihoker C, Marcovina SM, Mayer-Davis EJ, Hamman RF, Dolan L, Dabelea D, Pettitt DJ, Liese AD; SEARCH for Diabetes in Youth Study Group. Lawrence JM, et al. JAMA. 2021 Aug 24;326(8):717-727. doi: 10.1001/jama.2021.11165. JAMA. 2021. PMID: 34427600 Free PMC article. - Trends and racial and ethnic disparities in the prevalence of pregestational type 1 and type 2 diabetes in Northern California: 1996-2014.
Peng TY, Ehrlich SF, Crites Y, Kitzmiller JL, Kuzniewicz MW, Hedderson MM, Ferrara A. Peng TY, et al. Am J Obstet Gynecol. 2017 Feb;216(2):177.e1-177.e8. doi: 10.1016/j.ajog.2016.10.007. Epub 2016 Oct 15. Am J Obstet Gynecol. 2017. PMID: 27751798 Free PMC article. - Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective.
Fagot-Campagna A, Pettitt DJ, Engelgau MM, Burrows NR, Geiss LS, Valdez R, Beckles GL, Saaddine J, Gregg EW, Williamson DF, Narayan KM. Fagot-Campagna A, et al. J Pediatr. 2000 May;136(5):664-72. doi: 10.1067/mpd.2000.105141. J Pediatr. 2000. PMID: 10802501 Review. - Ethnic issues in the epidemiology of childhood obesity.
Crawford PB, Story M, Wang MC, Ritchie LD, Sabry ZI. Crawford PB, et al. Pediatr Clin North Am. 2001 Aug;48(4):855-78. doi: 10.1016/s0031-3955(05)70345-x. Pediatr Clin North Am. 2001. PMID: 11494640 Review.
Cited by
- Clinical utility of anti-Müllerian hormone in female children and adolescents.
Birbas E, Vatopoulou A, Kanavos T, Birmpas K, Skentou C, Zikopoulos A, Gkrozou F. Birbas E, et al. Hormones (Athens). 2024 Oct 31. doi: 10.1007/s42000-024-00603-5. Online ahead of print. Hormones (Athens). 2024. PMID: 39477856 Review. - Clinical Profile, Risk Factors, and Complications in Young-Onset Type 2 Diabetes Mellitus.
Dhadse R, Yadav D, Thakur L, Chavan S, Padhiyar R, Karatela S, Mulkalwar A. Dhadse R, et al. Cureus. 2024 Sep 3;16(9):e68497. doi: 10.7759/cureus.68497. eCollection 2024 Sep. Cureus. 2024. PMID: 39364487 Free PMC article. - Developing a Physical Activity Program for Mothers and Their Children at Risk for Diabetes.
Andreae SJ, Lindberg A, Casey T, Pickett KA. Andreae SJ, et al. Health Serv Res Manag Epidemiol. 2024 Sep 23;11:23333928241284178. doi: 10.1177/23333928241284178. eCollection 2024 Jan-Dec. Health Serv Res Manag Epidemiol. 2024. PMID: 39328808 Free PMC article. - The predictive utility of the in utero exposome for childhood adiposity in independent and integrated frameworks.
VanHawkins J, Peterson R, Harrall K, Moon B, Dabelea D, Kechris K, Perng W. VanHawkins J, et al. Pediatr Obes. 2024 Dec;19(12):e13172. doi: 10.1111/ijpo.13172. Epub 2024 Sep 26. Pediatr Obes. 2024. PMID: 39327854 - Population-based prevalence of self-reported pediatric diabetes and screening for undiagnosed type 2 diabetes in Chinese children in years 2017-2019, a cross-sectional study.
Wu W, Zhang JW, Li Y, Huang K, Chen RM, Maimaiti M, Luo JS, Chen SK, Wu D, Zhu M, Wang CL, Su Z, Liang Y, Yao H, Wei HY, Zheng RX, Du HW, Luo FH, Li P, Wang E, Polychronakos C, Fu JF. Wu W, et al. Lancet Reg Health West Pac. 2024 Sep 18;52:101206. doi: 10.1016/j.lanwpc.2024.101206. eCollection 2024 Nov. Lancet Reg Health West Pac. 2024. PMID: 39324120 Free PMC article.
References
- Imperatore G, Boyle JP, Thompson TJ, et al. SEARCH for Diabetes in Youth Study Group. Projections of type 1 and type 2 diabetes burden in the US population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care. 2012;35 (12):2515–2520. - PMC - PubMed
- Patterson CC, Gyürüs E, Rosenbauer J, et al. Trends in childhood type 1 diabetes incidence in Europe during 1989–2008: evidence of nonuniformity over time in rates of increase. Diabetologia. 2012;55 (8):2142–2147. - PubMed
- Vehik K, Hamman RF, Lezotte D, et al. Increasing incidence of type 1 diabetes in 0- to 17-year-old Colorado youth. Diabetes Care. 2007;30 (3):503–509. - PubMed
- Harjutsalo V, Sund R, Knip M, Groop PH. Incidence of type 1 diabetes in Finland. JAMA. 2013;310 (4):427–428. - PubMed
- Saydah S, Imperatore G, Geiss L, Gregg E Centers for Disease Control and Prevention. Diabetes death rates among youths aged ≤19 years—United States, 1968–2009. MMWR Morb Mortal Wkly Rep. 2012;61 (43):869–872. - PubMed
Publication types
MeSH terms
Grants and funding
- DP-05-069/DP/NCCDPHP CDC HHS/United States
- U48/CCU419249/PHS HHS/United States
- UL1 TR000154/TR/NCATS NIH HHS/United States
- U18 DP002714/DP/NCCDPHP CDC HHS/United States
- U01 DP000248/DP/NCCDPHP CDC HHS/United States
- U48/CCU919219/PHS HHS/United States
- P30 DK57516/DK/NIDDK NIH HHS/United States
- UL1 TR00423/TR/NCATS NIH HHS/United States
- U48/CCU519239/PHS HHS/United States
- U18DP002710-01/DP/NCCDPHP CDC HHS/United States
- UL1 RR029882/RR/NCRR NIH HHS/United States
- UL1 TR001082/TR/NCATS NIH HHS/United States
- UL1 TR000423/TR/NCATS NIH HHS/United States
- U01 DP000250/DP/NCCDPHP CDC HHS/United States
- P30 DK057516/DK/NIDDK NIH HHS/United States
- HIR 10-001/HX/HSRD VA/United States
- 1U18DP002709/DP/NCCDPHP CDC HHS/United States
- U48/CCU819241-3/PHS HHS/United States
- U01 DP000247/DP/NCCDPHP CDC HHS/United States
- U18 DP003256/DP/NCCDPHP CDC HHS/United States
- 8 UL1 TR000077/TR/NCATS NIH HHS/United States
- U18 DP002710/DP/NCCDPHP CDC HHS/United States
- U18DP002714/DP/NCCDPHP CDC HHS/United States
- U18DP002708-01/DP/NCCDPHP CDC HHS/United States
- 200-2010-35171/PHS HHS/United States
- DP-10-001/DP/NCCDPHP CDC HHS/United States
- U01 DP000244/DP/NCCDPHP CDC HHS/United States
- U18DP000247-06A1/DP/NCCDPHP CDC HHS/United States
- R01 DK104706/DK/NIDDK NIH HHS/United States
- U58/CCU019235-4/PHS HHS/United States
- U18 DP002709/DP/NCCDPHP CDC HHS/United States
- U18 DP006139/DP/NCCDPHP CDC HHS/United States
- K23 DK089017/DK/NIDDK NIH HHS/United States
- UL1 TR000077/TR/NCATS NIH HHS/United States
- U01 DP000254/DP/NCCDPHP CDC HHS/United States
- PA00097/PHS HHS/United States
- U01 DP000246/DP/NCCDPHP CDC HHS/United States
- U18 DP002708/DP/NCCDPHP CDC HHS/United States
- UL1RR029882/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical